Immunovant (IMVT) Stock: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$33.65
-0.13 (-0.38%)
▼
5d:
-1.03%
30d:
-15.66%
90d:
-13.25%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $33.65, which is considered oversold relative to its 30-day fair value range of $34.77 to $41.23.
Technical Outlook: Technically, IMVT is in a uptrend. Immediate support is located at $32.45, while resistance sits at $38.35.
Market Sentiment: IMVT scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.88 (+45.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMVT is in a uptrend. Immediate support is located at $32.45, while resistance sits at $38.35.
Market Sentiment: IMVT scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.88 (+45.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$34.77 -
$41.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding IMVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.2% below Wall St target ($48.88)
- CAUTION: Bottoming setup, but lagging the sector by 27% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$34.77 -
$41.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$32.45
Resistance Level
$38.35
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.02
Wall Street Target
$48.88
(+45.2%)
Share & Embed Analysis
Last updated: October 02, 2026 2:43 AM ET
Data refreshes hourly during market hours. Next update: 3:43 AM
Data refreshes hourly during market hours. Next update: 3:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao
SELL
25760 shares
2026-04-23
Jay S Stout
SELL
2754 shares
2026-04-23
Jay S Stout
SELL
10132 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 50 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 58 HOLD |
|
IMCR
Immunocore Holdings Ltd |
STRONG BUY
17 analysts |
$63 | 74 BUY |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
